We have located links that may give you full text access.
In vitro assessment of microbial barrier properties of Dermabond topical skin adhesive.
Surgical Infections 2002
BACKGROUND: Several different techniques are used for wound closure. Cyanoacrylate tissue adhesives are less invasive and easy to apply, and the cosmetic results are comparable to or better than the conventional methods for wound repair. The purpose of this study is to demonstrate that Dermabond Topical Skin Adhesive, 2-octylcyanoacrylate (a registered trademark of Ethicon) is an effective barrier against the penetration of microorganisms in an in vitro model.
MATERIALS AND METHODS: Octylcyanoacrylate adhesive was evaluated in vitro as a barrier to microbial penetration using a strike through test. Agar media containing pH sensitive dye was used. The dye changed color in the presence of acidic microbial metabolic products. Octylcyanoacrylate adhesive was applied to the agar surface to form uniformly thick films. A total of 300 single layered films and an additional 300 triple layered films were evaluated. A 10-microL aliquot of inoculum containing at least 1x10(3) cfu was applied to the surface of each film. Plates were incubated at 37 degrees C for 72 h and were observed for growth and color change every 24 h during the incubation period.
RESULTS: A series of binomial calculations were performed, varying the level of effectiveness of the test and the level of statistical confidence. Of the 600 test articles evaluated, 598 retained their patency at the end of 72 h. One individual test film was invalidated due to extrinsic contamination. The data presented indicated that octylcyanoacrylate tissue adhesive provided a barrier to microbial penetration with 95% confidence of 99% efficacy for 72 h in this in vitro model.
CONCLUSION: The results of these in vitro experiments supported the hypothesis that octylcyanoacrylate tissue adhesive is an effective barrier to microbial penetration by gram-positive and gram-negative motile and nonmotile species.
MATERIALS AND METHODS: Octylcyanoacrylate adhesive was evaluated in vitro as a barrier to microbial penetration using a strike through test. Agar media containing pH sensitive dye was used. The dye changed color in the presence of acidic microbial metabolic products. Octylcyanoacrylate adhesive was applied to the agar surface to form uniformly thick films. A total of 300 single layered films and an additional 300 triple layered films were evaluated. A 10-microL aliquot of inoculum containing at least 1x10(3) cfu was applied to the surface of each film. Plates were incubated at 37 degrees C for 72 h and were observed for growth and color change every 24 h during the incubation period.
RESULTS: A series of binomial calculations were performed, varying the level of effectiveness of the test and the level of statistical confidence. Of the 600 test articles evaluated, 598 retained their patency at the end of 72 h. One individual test film was invalidated due to extrinsic contamination. The data presented indicated that octylcyanoacrylate tissue adhesive provided a barrier to microbial penetration with 95% confidence of 99% efficacy for 72 h in this in vitro model.
CONCLUSION: The results of these in vitro experiments supported the hypothesis that octylcyanoacrylate tissue adhesive is an effective barrier to microbial penetration by gram-positive and gram-negative motile and nonmotile species.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app